CD4 and infection: Therefore, initiating treatment at diagnosis or when CD4 counts descend to a certain benchmark, such as 350 or 200 cells/mm3 (as recommended by current guidelines [25,47]), will mean that the highly infectious period of primary infection and the long period of incubation escape the controlling effects of treatment.